People who have had the Pfizer vaccine have fewer antibodies to the Delta (Indian) variant walesonline.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from walesonline.co.uk Daily Mail and Mail on Sunday newspapers.
Chris Hopson said the number of people in hospital with India variant was not increasing very significantly
Many in hospital in hotspot Bolton are younger than in earlier waves, therefore less at risk of complications
Matt Hancock said link between cases and deaths has been broken but not completely severed by vaccines
7 out of 9,427 vaccinated people infected with the new strain by the end of May were admitted to hospital
By comparison, 90 unvaccinated people were admitted in same time, figures published on Thursday showed
Anyone arriving back in the UK from the southern European country after that time will have to self-isolate for 10 days following its removal from the green travel list.
Covid latest: Important update for anyone who s had the Pfizer vaccine as Delta variant spikes cambridge-news.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cambridge-news.co.uk Daily Mail and Mail on Sunday newspapers.
Pfizer vaccine recipients have lower antibodies targeting Indian variant – study
Pfizer vaccine recipients have lower antibodies targeting Indian variant – study (Nick Potts/PA)
People who have had the Pfizer/BioNTech vaccine have lower antibody levels targeting the coronavirus variant first discovered in India than those against previously circulating variants in the UK, new data suggests.
The research also suggests the levels of these antibodies are lower with increasing age and that levels decline over time.
Researchers say this provides additional evidence in support of plans to deliver a vaccination boost to vulnerable people in the autumn.
The new laboratory data from the Francis Crick Institute and the National Institute for Health Research (NIHR) UCLH Biomedical Research Centre also supports current plans to reduce the dose gap between vaccines.